Beacon Endoscopic Ltd., a London, UK-based affiliate of Beacon Endoscopic Inc., a developer of interventional GI and bronchial endoscopy products, has secured $5m in financing from MVM Life Science Partners.
Boston, MA-based Beacon Endoscopic Inc. also said it had received a new round of capital from its existing investors.
In conjunction with the financing, Dr. Stephen Reeders, a founding partner at MVM, will join Beacon Endoscopic Inc.’s board, alongside CEO Peter Rogal and co-founders Brian Tinkham and Christopher Thompson, MD.
The company intends to use the funds to commercialize its products globally.
Beacon has developed the BNX™ System, a novel fine needle aspiration system (FNA) for use in endoscopic ultrasound (EUS) and endoscopic bronchial ultrasound (EBUS). The EUS BNX™ System has received FDA clearance and will be launched in the U.S. in the fourth quarter of 2011.